Among paediatric patients, budesonide inhaled suspension (BIS) recipients have a reduced risk of asthma-related hospitalisation recurrence

Source: Inpharma, Volume 1, Number 1599, 2007-08-04 , pp. 14-14(1)

Publisher: Adis International

Keywords: Asthma, treatment; Beta-2-adrenergic-receptor-agonists, therapeutic u; Budesonide, therapeutic use; Children; Corticosteroids, therapeutic use; Hospitalisation; Infants; Leukotriene-antagonists, therapeutic use; Mast-cell-stabilisers, therapeutic use; Neonates

Document Type: Research article

Publication date: 2007-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers